Gainesville, FL Clinical Trials Report — May 2026

For patients and healthy volunteers in Gainesville, FL, May 2026 brings both urgent opportunities to participate in clinical research and new avenues for contributing to medical science. With a total of 531 clinical trials currently recruiting across 173 research facilities in the city, Gainesville continues to be a vibrant center for medical innovation.

A number of trials are nearing their enrollment deadlines, making prompt action essential for interested individuals. There are currently 36 clinical trials slated to conclude within the next 90 days. This urgency is particularly relevant for healthy volunteers, as 9 of these rapidly closing studies are still actively seeking participants without specific health conditions, offering a chance to contribute to medical advancements before their enrollment windows close.

Upcoming Deadlines for Key Health Areas

Patients managing specific health conditions also face impending deadlines to join research. Trials focused on various conditions are among those with limited time remaining for enrollment. Conditions with trials closing soon include:

• Sepsis (2 trials)
• Acute myeloid leukemia (1 trial)
• Aortic insufficiency (1 trial)
• Advanced solid tumors (1 trial)
• Anxiety (1 trial)
• Aortic aneurysm, abdominal (1 trial)
• Advanced malignant solid neoplasm (1 trial)
• Aortic regurgitation (1 trial)
• Aortic valve insufficiency (1 trial)
• Attention-deficit/hyperactivity disorder (1 trial)

New Research Opportunities Emerge in May

This month, Gainesville saw the opening of 6 new clinical trials, a slight increase from the 5 trials that launched in April 2026. This consistent opening of new studies ensures a steady stream of opportunities for participation.

For individuals without a specific medical condition, there are significant opportunities to contribute to research. Of the 6 new trials launched this month, 1 is actively seeking healthy volunteers. Across Gainesville, a total of 71 clinical trials are currently recruiting healthy participants, providing numerous avenues for those interested in supporting medical research.

May brings several notable new trials to Gainesville, including studies from major sponsors. These trials offer participants the chance to engage with cutting-edge treatments and diagnostic approaches across a range of health challenges.

• The University of Florida is sponsoring NCT07581379, "Advancing Precision Lung Cancer Surveillance and Outcomes in Diverse Populations." This observational study aims for 1,826 participants and evaluates the effectiveness of computed tomography (CT) imaging surveillance after curative-intent treatment for stage I-IIIA non-small cell lung cancer (NSCLC) in a diverse U.S. population.
• Eli Lilly and Company is initiating a significant Phase 2 study, NCT07589595, "A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)." This trial aims for 350 participants to evaluate whether treatment with donanemab, a drug known for its role in Alzheimer's research, slows the progression of cognitive and functional decline in individuals with early cognitive decline.

New trials this month are exploring a range of conditions, including amyloid, blood transfusion, brain metastases, carotenoids, cognitive dysfunction, Lewy body disease, lung cancer (diagnosis), lung neoplasms, mortality, and non-small cell lung cancer (NSCLC), stage I-IIIA. The majority of new studies are classified as BIOLOGICAL (2 trials) or DRUG (1 trial).

Who Can Participate in New Trials?

Participation in clinical trials is open to a diverse range of individuals. Of the 6 new trials launched this month, 5 include older adults, ensuring that senior populations have ample opportunity to contribute to medical science. Additionally, 2 new trials include children, and 1 is male-only. The University of Florida is a leading sponsor of new research this month, initiating 4 of the new studies, alongside industry sponsor Eli Lilly and Company.

Gainesville's Leading Research Facilities

Gainesville is home to several prominent research institutions that consistently run a high volume of clinical trials. These facilities are key destinations for individuals seeking to participate in medical research:

• University of Florida (188 trials)
• UF Health Cancer Institute - Gainesville (58 trials)
• Research Site (16 trials)
• North Florida/South Georgia Veterans Health System, Gainesville, FL (11 trials)
• University of Florida Health (11 trials)
• Malcom Randall Veterans Administration Medical Center (8 trials)
• University of Florida College of Medicine (7 trials)
• UF Health (7 trials)
• UF Health Shands Hospital (7 trials)
• Vitreo Retinal Associates (7 trials)
• University of Florida Shands Hospital (6 trials)
• The Cardiac and Vascular Institute (6 trials)

The University of Florida and its affiliated UF Health facilities are clearly the dominant forces in Gainesville's research landscape, offering a broad spectrum of studies across various medical fields, from cancer research at the UF Health Cancer Institute to general health at UF Health and specialized care at UF Health Shands Hospital.

Broadening Your Search: Beyond Gainesville

While Gainesville offers a robust array of clinical trial opportunities, individuals may also find options in nearby communities within Florida. Cities with active trials include Miami (23 trials), Jacksonville (12 trials), Orlando (9 trials), Tampa (9 trials), Winter Park (6 trials), Maitland (5 trials), Miami Lakes (4 trials), and Coral Gables (4 trials).

As we move further into spring, Gainesville's dedicated research community will continue to drive medical innovation, offering diverse opportunities for individuals to contribute to the future of healthcare and improve patient outcomes.